2009 Center Bibliography
Center for Cardiovascular Innovation
Bibliography
2009
Original Articles
Albert NM, Fonarow GC, Abraham WT, Gheorghiade M, Greenberg BH, Nunez E, O'Connor CM, Stough WG, Yancy CW, Young JB. Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. Am J Med. 2009;122:366-373.
Betti I, Castelli G, Barchielli A, Beligni C, Boscherini V, De Luca L, Messeri G, Gheorghiade M, Maisel A, Zuppiroli A. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure: the PROBE-HF study. J Card Fail. 2009;15:377-384.
Blair JE, Khan S, Konstam MA, Swedberg K, Zannad F, Burnett JC Jr, Grinfeld L, Maggioni AP, Udelson JE, Zimmer CA, Ouyang J, Chen CF, Gheorghiade M; EVEREST Investigators. Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial. Eur Heart J. 2009;30:1666-1673.
Bonow RO. Should coronary calcium screening be used in cardiovascular prevention strategies? N Engl J Med. 2009;361: 990-997.
Brush JE, Rensing E, Cook S, Lynch J, Thacker L, Song F, Gurram S, Bonow RO, Brough J, Valentine M. A state-wide collaborative initiative to improve the quality of care for patients with acute myocardial infarction and heart failure. Circulation. 2009;119:1609-1615.
Curtis AB, Yancy CW, Albert NM, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, Oconnor CM, Reynolds D, Walsh MN, Fonarow GC. Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J. 2009;158:956-964.
Donlan SM, Quattromani E, Pang PS, Gheorghiade M. Therapy for acute heart failure syndromes. Curr Cardiol Rep. 2009;11:192-201.
Douglas PS, Taylor A, Bild D, Bonow RO, Greenland P, Lauer M, Peacock F, Udelson JE. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart Lung and Blood Institute. J Am Coll Cardiol Img 2009;2:897-907; Circulation Imaging 2009;2:339-348; J Am Soc Echocardiogr 2009;22:766-773; and J Cardiovasc Comput Tomogr 2009;3:2122-23.
Farmakis D. Filippatos G. Parissis J. Kremastinos DT. Gheorghiade M. Hyponatremia in heart failure. Heart Fail Rev. 2009;14:59-63.
Flaherty JD, Bax JJ, De Luca L, Rossi JS, Davidson CJ, Filippatos G, Liu PP, Konstam MA, Greenberg B, Mehra MR, Breithardt G, Pang PS, Young JB, Fonarow GC, Bonow RO,Gheorghiade M. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J Am Coll Cardiol. 2009;53:254-262.
Flaherty JD, Rossi JS, Fonarow GC, Nunez E, Stough WG, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, Yancy CW, Young JB, Davidson CJ, Gheorghiade M. Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2009;157:1018-1025.
Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy C, Young JB. Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). Am J Cardiol. 2009;104:107-115.
Fuster V, van der Zee S, Elmariah S, Bonow RO. Academic careers in cardiovascular medicine. Circulation. 2009;119: 754-760.
Gheorghiade M, Adams KF, Cleland JG, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Piña IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J. 2009;157:957-970.
Gheorghiade M. Braunwald E. Reconsidering the role for digoxin in the management of acute heart failure syndromes. JAMA. 2009;302:2146-2147.
Gheorghiade M, Harinstein ME, Filippatos GS. Digoxin for the treatment of chronic and acute heart failure syndromes. Acute Card Care. 2009;11:83-87.
Gheorghiade M, Khan S, Blair JE, Harinstein ME, Krum H, Mukherjee R, Pitt B. The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction. Am Heart J. 2009;158:437-443.
Gheorghiade M, Pang PS. Are BNP changes during hospitalization for heart failure a reliable surrogate for predicting the effects of therapies on post-discharge mortality? J Am Coll Cardiol. 2009;53:2349-2352.
Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53:557-573.
Gheorghiade M, Pang PS. Are BNP changes during hospitalization for heart failure a reliable surrogate for predicting the effects of therapies on post-discharge mortality? J Am Coll Cardiol. 2009;53:2349-2352.
Grady K, Wang E, Higgins R, Heroux A, Rybarczyk B, Young JB, Pelegrin D, Czerr J, Kobashigawa J, Chait J, Naftel DC, White-Williams C, Myers S, Kirklin J. Symptom frequency and distress from 5 to 10 years after heart transplantation. J Heart Lung Transplant. 2009;28:759-768.
Harinstein ME, Filippatos GS, Gheorghiade M. Acute heart failure syndromes: epidemiology, risk stratification and prognostic factors. Acute Card Care. 2009;11:77-82.
Harinstein ME, Filippatos GS, Gheorghiade M. Acute heart failure syndromes: the role of vasopressin antagonists. Acute Card Care. 2009;11:61-65.
Helber I, Dos Santos AA, Antonio EL, Flumignan RL, Bocalini DS, Piccolo C,Gheorghiade M, Tucci PJ. Digitoxin prolongs survival of female rats with heartfailure due to large myocardial infarction. J Card Fail. 2009;15:798-804.
Huffman MD, Bonow RO. Clinical practice guidelines and scientific evidence. JAMA. 2009; 302:144-145
Jones DW, Peterson ED, Bonow RO, Bufalino V, Franklin B, Gardner T, Sacco R, Redberg R, Meltzer N, Solis P, Girgus M, Hinton P, Leonard A, Gibbons RJ. Partnering with patients to reduce risks and improve cardiovascular outcomes: American Heart Association initiatives in action. Circulation. 2009:119: 340-350.
Kadish AH, Bello D, Finn P, Bonow RO, Schaechter A, Subacius H, Albert C, Dauberrt J, Goldberger JJ. Defibrillators to Reduce Risk by Magnetic Resonance Imaging (DETER-MINE). J Cardiovasc Electrophysiol. 2009;20:982–987.
Kim HW, Klem I, Shah DJ, Wu, E, Meyers SN, Parker MA, Crowley AL, Bonow RO, Judd RM, Lim RJ. Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary artery disease. PLOS Medicine. 2009;6:e100000057.doi:10.1371/journal. pmed.1000057
Mebazaa A, Pang PS, Tavares M, Collins SP, Storrow AB, Laribi S, Andre S, Courtney DM, Hasa J, Spinar J, Masip J, Peacock WF, Sliwa K, Gayat E, Filippatos G, Cleland JG, Gheorghiade M. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J. 2009;Nov 11. [Epub ahead of print] PubMed PMID: 19906690.
Mehra MR, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, O'Connor CM, Reynolds D, Walsh MN, Fonarow GC. Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. Heart Rhythm. 2009;6:1727-1734.
Mendes de Leon CF, Grady K, Powell LH, Calvin J, Richardson D, Rucker-Whitaker C. Quality of life in heart failure patients: baseline data from the Heart Failure Adherence and Retention (HART) trial. J Cardiopulm Rehab. 2009;29:171-178.
Pang PS, Gheorghiade M. Special cases in acute heart failure syndromes: atrial fibrillation and wide complex tachycardia. Heart Failure Clin. 2009;5:113-123.
Pang PS, Konstam MA, Krasa HB, Swedberg K, Zannad F, Blair JE, Zimmer C, Teerlink JR, Maggioni AP, Burnett JC Jr, Grinfeld L, Ouyang J, Udelson JE, Gheorghiade M. Effects of tolvaptan on dyspnoea relief from the EVEREST trials. Eur Heart J. 2009;30:2233-2240.
Peacock WF, Fonarow GC, Ander DS, Collins SP, Gheorghiade M, Kirk JD, Filippatos G, Diercks DB, Trupp RJ, Hiestand B, Amsterdam EA, Abraham WT, Amsterdam EA, Dodge G, Gaieski DF, Gurney D, Hayes CO, Hollander JE, Holmes K, Januzzi JL Jr, Levy P, Maisel A, Miller CD, Pang PS, Selby E, Storrow AB, Weintraub NL, Yancy CW, Bahr RD, Blomkalns AL, McCord J, Nowak RM, Stomel RJ..Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart falure patient. Acute Card Care. 2009;11:3-42.
Petroski RA, Grady KL, Sullivan C, Rodgers S, Backer CL, Pahl E. Quality of life in adult survivors greater than 10 years post pediatric heart transplantation: a pilot study. J Heart Lung Transplant. 2009;28:661-666.
Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO.The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol. 2009;54:2251-2260.
Pitt B, Zannad F, Gheorghiade M, Martínez F, Love TE, Daniel C, Ahmed A. Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: A propensity-matched study of the EPHESUS trial. Int J Cardiol. 2009 Apr 14. [Epub ahead of print] PubMed PMID: 19371959.
Riegel B, Moser D, Anker S, Appel L, Dunbar S, Grady K, Gurvitz M, Havranek E, Lee C, Lindenfeld J, Peterson P, Pressler S, Schocken D, Whellan D. State of the science: promoting self-care in persons with heart failure. A statement from the American Heart Association. Circulation. 2009;120: 1141-1163.
Shah SJ, Blair JE, Filippatos GS, Macarie C, Ruzyllo W, Korewicki J, Bubenek-Turconi SI, Ceracchi M, Bianchetti M, Carminati P, Kremastinos D, Grzybowski J, Valentini G, Sabbah HN, Gheorghiade M. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neuro-hormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. Am Heart J. 2009;157:1035-1041.
Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EAM, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. The Role of intensive glycemic control in the prevention of cardiovascular disease: implications of the ACCORD, ADVANCE, and VADT studies. Diabetes Care 2009;32:187-192; Circulation. 2009: 119:351-357; J Am Coll Cardiol. 2009;53:298-304.
Thomas J, Zoghbi WA, Beller GA, Bonow RO, Budoff MJ, Cerqueira M, Creager MA, Douglas PS, Garcia MJ, Holmes DR, Manning WJ, Pohost GM, Ryan TJ, Van Decker WA, Wiegers SE. ACCF training statement on multimodality non-invasive cardiovascular imaging. a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J Am Coll Cardiol. 2009;53:125-146.
Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J. 2009; 157:754-762.
Monograph
Fisher ES, Weiss K, Becker L, Bonow RO, Clancy CM, de Brantes F, Dubow J, Golden WE, Ho S, Hopkins DSP, Isham GJ, Izui C, Jarris PE, Krughoff RM, Martin L, Naylor MD, O’Kane ME, Patton RM, Perlin JB, Queram CJ, Rattray MC, Sennett C, Valuck T, VanAmringe M, Weinstein J. Measurement Framework: Evaluating Efficiency Across Patient-Focused Episodes of Care. Washington, DC: National Quality Forum, 2009;1-18.
Books
Otto CM, Bonow RO. Valvular Heart Disease. A Companion to Braunwald’s Heart Disease. Philadelphia: Elsevier Science, 2007: pp 452.
Chapters
Bonow RO. Foreword. In: Hundley WG, Kramer CM, eds. Cardiovascular Magnetic Resonance: A Companion to Braunwald’s Heart Disease. Philadelphia: Elsevier Science. 2009:ix-xi.
Bonow RO. Foreword. In: Hutchinson S. Pericardial Diseases: Clinical Diagnostic Imaging Atlas. Philadelphia: Saunders/Elsevier. 2009:vii.
Bonow RO. Foreword. In: Taylor AJ, ed. Cardiovascular Computed Tomography: A Companion to Braunwald’s Heart Disease. Philadelphia: Elsevier Science. 2009:xiii-xiv.
Bonow RO. Guidelines for the management of patients with valvular heart disease. In: Fuster V, ed. The AHA Guideline and Scientific Statement Handbook. Oxford: John Wiley & Sons. 2009:293-311.
Maganti K, Rigolin VH, Bonow RO. Aortic regurgitation. In; Garcia MJ, ed. Textbook of Non-Invasive Cardiovascular Imaging. Baltimore: Lippincott, Williams & Wilkins. 2009: 393-413.
O’Gara PT, Bonow RO, Otto CM. Prosthetic Heart Valves. In: Otto CM, Bonow RO, eds. Valvular Heart Disease. A Companion to Braunwald’s Heart Disease. Philadelphia: Elsevier Science. 2009:383-398.
Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. In: Picano E, ed. Stress Echocardiography. Berlin: Springer Verlag. 2009:499-522.
Rigolin VH, Bonow RO. Aortic regurgitation. In: Wang A, Bashore TM, eds. Valvular Heart Disease. New York: Humana Press. 2009:187-206.
Rigolin VH, Bonow RO. Valvular heart disease. In: Ferdinand KC. ed. Educational Review Manuel in Cardio-vascular Disease. New York: Castle Connolly Publishing, Ltd. 2009:577-617.
Taylor AJ, Bonow RO. Can atherosclerosis imaging improve patient management? In: Di Carli MF, Kwing RY, eds. Novel Techniques For Imaging the Heart. Oxford: John Wiley & Sons. 2009:244-258.
Tornos P, Bonow RO. Aortic regurgitation. In: Otto CM, Bonow RO, eds. Valvular Heart Disease. A Companion to Braunwald’s Heart Disease. Philadelphia: Elsevier Science. 2009:155-168.
